You need JavaScript to view this

Compounds for the treatment of calcific tumors

Patent:

Abstract

The preparation of a radioactive polyphosphonate compound tagged with either /sup 32/P or /sup 33/P radionuclide is described. The radiopharmaceutical is effective for producing therapeutic or pain relieving doses of radiation that can be directed toward bone tumor sites without a substantial risk of radiation damage to the remainder of the body.
Publication Date:
May 21, 1974
Product Type:
Patent
Report Number:
A
Reference Number:
AIX-07-241905; EDB-76-071670
Resource Relation:
Other Information: Open to public inspection 27 Nov 1975, priority USA 23 May 1973, copies available from the Commissioner of Patents, Canberra
Subject:
38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY; PHOSPHONIC ACID ESTERS; LABELLING; RADIOPHARMACEUTICALS; CHEMICAL PREPARATION; BONE SEEKERS; OSTEOSARCOMAS; PHOSPHORUS 32; PHOSPHORUS 33; POLYMERS; THERAPY; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; ESTERS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANIC PHOSPHORUS COMPOUNDS; PHOSPHORUS ISOTOPES; RADIOACTIVE MATERIALS; RADIOISOTOPES; SARCOMAS; SKELETAL DISEASES; SYNTHESIS; 400702* - Radiochemistry & Nuclear Chemistry- Properties of Radioactive Materials
OSTI ID:
7346514
Country of Origin:
Australia
Language:
English
Submitting Site:
INIS
Size:
Pages: 41
Announcement Date:

Patent:

Citation Formats

Francis, M D, Tofe, A J, and Lampe, H W. Compounds for the treatment of calcific tumors. Australia: N. p., 1974. Web.
Francis, M D, Tofe, A J, & Lampe, H W. Compounds for the treatment of calcific tumors. Australia.
Francis, M D, Tofe, A J, and Lampe, H W. 1974. "Compounds for the treatment of calcific tumors." Australia.
@misc{etde_7346514,
title = {Compounds for the treatment of calcific tumors}
author = {Francis, M D, Tofe, A J, and Lampe, H W}
abstractNote = {The preparation of a radioactive polyphosphonate compound tagged with either /sup 32/P or /sup 33/P radionuclide is described. The radiopharmaceutical is effective for producing therapeutic or pain relieving doses of radiation that can be directed toward bone tumor sites without a substantial risk of radiation damage to the remainder of the body.}
place = {Australia}
year = {1974}
month = {May}
}